Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2010 Dec 14;122(24):2495-8.
doi: 10.1161/CIRCULATIONAHA.110.991059. Epub 2010 Nov 29.

T cells and blood vessels: costimulation turns up the pressure

De-Xiu Bu, Andrew H Lichtman
Editorial

T cells and blood vessels: costimulation turns up the pressure

De-Xiu Bu et al. Circulation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors have declared that no conflict of interest exists.

Figures

Figure
Figure
Hypothetical scheme for induction of T cell responses in hypertension. This scheme is based on a scheme proposed in Harrison et al. with a refocus costimulation of T cells. A. Mild hypertension is initially induced by angiotensin II (Ang II) or high salt, leading to limited vascular wall damage, release of DAMPs and altered self proteins. DAMPs activate dendritic cells (DCs) via TLR signaling, inducing costimulator expression (CD80, CD86). The activated DCs process the altered self proteins and displays peptides from those proteins bound to MHC molecules. B. The DC presents the neoantigen peptide/MHC complexes and costimualtors to naive T cells specific for that antigen, and the T cells are activated, proliferate and differentiation into pathogenic effector T cells specific for altered vessel wall proteins. These T cells infiltrate around blood vessels, become reactivated in that location (not shown), and secrete inflammatory cytokines that further promote vascular dysfunction leading to severe hypertension. More neoantigens and DAMPs will be released from the vessels in severe hypertension, amplifying the T cell response. C. CTLA-4-Ig blocks the interaction of CD80 and CD86 with T cell CD28, thereby preventing naïve T cell activation, and theoretically preventing the pro-hypertensive T cell response shown in B.
See this image and copyright information in PMC

Comment on

References

    1. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tor M, Billiar T. The grateful dead: Damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev. 2007;220:60–81. - PubMed
    1. Jeannin P, Jaillon S, Delneste Y. Pattern recognition receptors in the immune response against dying cells. Curr Opin Immunol. 2008;20:530–537. - PubMed
    1. Gotsman I, Sharpe AH, Lichtman AH. T-cell costimulation and coinhibition in atherosclerosis. Circ Res. 2008;103:1220–1231. - PMC - PubMed
    1. Linsley PS, Nadler SG. The clinical utility of inhibiting cd28-mediated costimulation. Immunol Rev. 2009;229:307–321. - PubMed
    1. Schiff M. Abatacept treatment for rheumatoid arthritis. Rheumatology - PMC - PubMed